We recently issued an updated research report on ZTO Express (Cayman) ZTO. The stock has been downgraded to a Zacks Rank #5 (Strong Sell) from a Zacks Rank #3 (Hold). Going by the proven Zacks model, the Sell-rated stocks (#4 or 5) are likely to underperform the broader market over the next one to three months.
Reasons for the Downgrade
High-operating expenses have been hurting the bottom period, total operating expenses at this China-based company surged 49.7% to RMB 499.7 million.
Higher selling, general and administrative (SG&A) expenses induced a rise in the operating expenses. Apart from other factors, increase in salary and accrued bonus escalated SG&A expenses during the reported quarter.
We are also concerned about the company’s gross margin contraction in the first quarter of 2019. The metric declined to 27.5% in the quarter under review from 29.1% a year ago. This downside was due to expansion in parcel volumes and cost productivity gain. In fact, the company delivered lower-than-expected earnings per share in the period under consideration.
Moreover, the company’s business suffers stringent government regulations and strict policies of the Chinese market. Additionally, the domestic express delivery market is highly competitive due to the presence of big players like SF Express and STO Express.
The bearish sentiments revolving around the stock can be further gauged from the Zacks Consensus Estimate being revised 8.3% downward in the last 60 days for current-year earnings. Moreover, shares of this China-based company have declined 8.4% over the past three months against its industry’s rise of 3.3%.
Three-Month Price Performance
The company’s Momentum Score of D highlights its stock’s short-term unattractiveness.
Stocks to Consider
Some better-ranked stocks in the broader Transportation sector are SkyWest SKYW, GATX Corporation GATX and Trinity Industries TRN, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Shares of SkyWest have surged more than 34% so far this year. Meanwhile, both GATX and Trinity boast an encouraging earnings history. While GATX outpaced the Zacks Consensus Estimate in each of the trailing four quarters, Trinity surpassed estimates in three of the previous four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SkyWest, Inc. (SKYW) : Free Stock Analysis Report
GATX Corporation (GATX) : Free Stock Analysis Report
Trinity Industries, Inc. (TRN) : Free Stock Analysis Report
ZTO Express (Cayman) Inc. (ZTO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research